AbCellera

AbCellera Reports Positive Phase 2 Results for ABCL635

VANCOUVER, British Columbia, August 10, 2026 AbCellera Biologics Inc. announced positive topline results from the Phase 2 portion of...

By cGxPwire Editor
August 11, 2026

Bio-Pharma

AbCellera to Announce ABCL635 Phase 2 Results

VANCOUVER, British Columbia, August 7, 2026 AbCellera announced that it will release top-line results from the Phase 2 clinical...

By cGxPwire Editor
August 8, 2026

Bio-Pharma

AbCellera Partners with Vertex to Develop Multispecific T-Cell Engagers

VANCOUVER, British Columbia, July 29, 2026 AbCellera Biologics Inc. announced a strategic collaboration with Vertex Pharmaceuticals to research, develop,...

By cGxPwire Editor
July 30, 2026

Bio-Pharma

Jazz and AbCellera Partner on Next-Gen Cancer Antibodies

DUBLIN, Ireland and VANCOUVER, British Columbia, June 17, 2026 Jazz Pharmaceuticals and AbCellera have announced a major strategic collaboration...

By cGxPwire Editor
June 18, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

AbCellera Reports Positive Phase 2 Results for ABCL635

AbCellera to Announce ABCL635 Phase 2 Results

AbCellera Partners with Vertex to Develop Multispecific T-Cell Engagers

Jazz and AbCellera Partner on Next-Gen Cancer Antibodies